Sandra P. D'Angelo, MD
Dr
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Dejka M. Araujo, MD
Professor
University of Texas MD Anderson Cancer Center
Houston, Texas, United States
Albiruni R. A. Razak, MRCP, MBBCh (he/him/his)
Clinician Investigator
Princess Margaret Cancer Centre
Toronto, Ontario, Canada
Andrew J. S. Furness, MD, PhD
Consultant Medical Oncologist
The Royal Marsden NHS Foundation Trust
London, England, United Kingdom
Brian A. Van Tine, MD, PhD
Professor of Medicine
Washington University in St Louis School of Medicine
St. Louis, Missouri, United States
Mihaela Druta, MD
Vice Chair, Sarcoma Department
Moffitt Cancer Center
Tampa, Florida, United States
Melissa A. Burgess, MD
Assistance Professor
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Fiona Thistlethwaite, MB, BChir, PhD, MRCP
Medical Oncology Consultant
The Christie NHS Foundation Trust and University of Manchester
Manchester, England, United Kingdom
Anna W. Chalmers, MD (she/her/hers)
Associate Professor
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
.jpg "John B.A.G Haanen, MD, PhD (he/him/his) photo")
John B.A.G Haanen, MD, PhD (he/him/his)
Research Group Leader
Netherlands Cancer Institute
Amsterdam, Noord-Holland, Netherlands
Jonathan Noujaim, MD (he/him/his)
Associate Professor of Medicine
Hôpital Maisonneuve-Rosemont and McGill University Health Center
Montreal, Quebec, Canada
Richard F. Riedel, MD
Medical Oncologist
Duke Cancer Institute
Durham, North Carolina, United States
David A. Liebner, MD
Associate Professor in the College of Medicine
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Neeta Somaiah, MD (she/her/hers)
Professor and Department Chair
Department of Sarcoma Medical Oncology, Division of Cancer Medicine, MD Anderson Cancer Center
Houston, Texas, United States
Warren A. Chow, MD
Associate Director for Clinical Science
UCI Health Chao Family Comprehensive Cancer Center, University of California
Irvine, California, United States
Rashmi Chugh, MD
Professor of Internal Medicine
University of Michigan Rogel Comprehensive Cancer Center
Ann Arbor, Michigan, United States
Lara E. Davis, MD
Sarcoma Program Director
Knight Cancer Institute, Oregon Health & Science University
Portland, Oregon, United States
Ana Sebio García, MD, PhD
Medical Oncologist
Hospital de la Santa Creu i Sant Pau, IR Sant Pau
Barcelona, Catalonia, Spain
Mark Agulnik, MD
Sarcoma Medical Oncology
USC Norris Comprehensive Cancer Center, University of Southern California
Los Angeles, California, United States
Edouard Forcade, MD
Professor
Centre Hospitalier Universitaire de Bordeaux – Hôpital Haut-Lévêque
Bordeaux, Ile-de-France, France
Michael J. Wagner, MD
Clinical Research Director
Dana-Farber Cancer Institute
Boston, Massachusetts, United States
Stephan A. Grupp, MD, PhD
Medical Director of the Cell and Gene Therapy Laboratory
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Scott M. Schuetze, MD, PhD (he/him/his)
Clinical Professor of Internal Medicine
University of Michigan
Ann Arbor, Michigan, United States
Michael Carlton, MSc
Principal Programmer
Adaptimmune
Abingdon, England, United Kingdom
Beth Ireland, MSc
Principal Biostatistician, QDS
Adaptimmune
Abingdon, England, United Kingdom
Erin Van Winkle, n/a
Sr. Director Clinical Programs
Adaptimmune
Philadelphia, Pennsylvania, United States
Michael J. Nathenson, MD (he/him/his)
Senior Medical Director
US World Meds
Boston, Massachusetts, United States
Dennis Williams, PharmD
Senior Vice President, Late Stage Development
Adaptimmune
Philadelphia, Pennsylvania, United States
Elliot Norry, MD
Chief Medical Officer
Adaptimmune
Philadelphia, Pennsylvania, United States
John W. Glod, MD, PhD (he/him/his)
Senior Clinician
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Bethesda, Maryland, United States
